Evaluation of Handling and Possible Complications Related to the Newly Developed Angular Stable Locking System (ASLS)

Femur Fracture Clinical Trial

— ASLS-Pre  

Official title:

Prospective Multicenter Case Series to Evaluate Handling and Possible Complications Related to the Angular Stable Locking System in Patients With Proximal and Distal Tibial, Femoral and Humeral Fractures Treated With Intramedullary Nails

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00793637
• Other study ID #: ASLS-Pre-08
• Status: Completed
• Start date: August 2008
• Est. completion date: August 2009

Study information

• Verified date: August 2009
• Source: AO Innovation Translation Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In many cases, the existing locking bolts and screws in intramedullary nails do not provide sufficient stability. Due to the play between screw and nail, the reduction can be lost and the instability can result in malunions, nonunions, or pseudoarthrosis. Consequently, secondary angular fracture dislocation (defined as a difference of the angle of 10° or more from the post-operative to the follow-up x-rays) can be observed in approximately 30% of patients after conventional intramedullary nailing of proximal third tibial fractures and in approximately 0-2% in patients with distal third tibial fractures. Therefore, an Angular Stable Locking System for Intramedullary Nails (ASLS) was developed to reduce the risk of secondary loss of reduction by providing axial and angular stability. ASLS provides angular stable fixation between nails and screws with resorbable sleeves used as dowels in the nail locking holes.

The present study evaluates the handling of ASLS and the surgeon's compliance as well as any complications occurring during the baseline and the follow-up period in patients with proximal and distal tibial, femoral and humeral fractures treated with intramedullary nails. Furthermore, the relationship of any occurred complications to ASLS will be assessed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: August 2009
• Est. primary completion date: July 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• The patient is = 18 years old

• One of the following bones is fractured so that the fracture is affecting the proximal or the distal third of the bone without affecting the joint surface: Humerus, Femur, Tibia

• The fracture is fixed with one of the following cannulated implants Humerus: Expert HN, Expert PHN. Femur: Expert LFN, Expert RAFN, CFN, DFN, AFN. Tibia: Expert TN, CTN.

• The patient is willing and able to participate in the study follow-up according to the CIP.

• The patient is able to understand and read local language at elementary level.

• The patient is willing and able to give written informed consent to participate in the study.

Exclusion criteria:

• The patient is legally incompetent.

• Preexistent malunion or nonunion of the bone that is planned to be treated with ASLS.

• The patient suffers from a polytrauma (multiple injuries, whereof one or the combination of several injuries is life-threatening).

• The patient suffers from active malignancy.

• The patient is affected by drug or alcohol abuse.

• The patient has participated in any other device or drug related clinical trial within the previous month.

Related Conditions & MeSH terms

• Femoral Fractures
• Femur Fracture
• Fractures, Bone
• Humeral Fractures
• Humerus Fracture
• Tibia Fracture
• Tibial Fractures

Locations

Country	Name	City	State
Austria	Medizinische Universität Innsbruck, Abteilung Unfallchirurgie und Sporttraumatologie	Innsbruck
Germany	Charité - Universitätsmedizin Berlin, Centrum für Muskuloskeletale Chirurgie	Berlin
Germany	Universitätsklinikum Mainz, Klinik und Poliklinik für Unfallchirurgie	Mainz
Germany	BG Unfallklinik Tübingen	Tuebingen

Sponsors (2)

Lead Sponsor	Collaborator
AO Clinical Investigation and Publishing Documentation	Synthes Inc.

Countries where clinical trial is conducted

Austria,  Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Surgeon's compliance and handling-oriented questionnaire		During surgery
Secondary	Rate of Complications		6 months
Secondary	General pain and pain at fracture site assessed by VAS		6 months
Secondary	Walking ability in patients with femoral or tibial fractures using the Parker mobility score		6 months